BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4176638)

  • 1. Studies on the immunological properties of LATS.
    Ochi Y; DeGroot LJ
    Endocrinology; 1968 Oct; 83(4):845-54. PubMed ID: 4176638
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the antigen reacting with the thyroid-stimulating immunoglobulin (LATS) in thyrotoxicosis.
    Benhamou-Glynn N; el-Kabir DJ; Roitt IM; Doniach D
    Immunology; 1969 Feb; 16(2):187-204. PubMed ID: 4181510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental production of a thyroid-stimulating antithyroid antibody.
    McKenzie JM
    J Clin Endocrinol Metab; 1968 May; 28(5):596-602. PubMed ID: 4172455
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid-stimulating activity in the serum of immunized rabbits. II. Nature of the thyroid-stimulating material.
    Solomon DH; Beall GN
    J Clin Endocrinol Metab; 1968 Oct; 28(10):1496-502. PubMed ID: 5681643
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
    Mori T; Fisher J; Kriss JP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid-stimulating activity in the serum of rabbits immunized with thyroid microsomes.
    Beall GN; Solomon DH
    J Clin Endocrinol Metab; 1968 Apr; 28(4):503-10. PubMed ID: 4868496
    [No Abstract]   [Full Text] [Related]  

  • 8. LATS and thyroid autoantibodies.
    Beall GN; Solomon DH
    Clin Exp Immunol; 1968 Sep; 3(7):615-9. PubMed ID: 4883066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of immunologic reaction of long acting thyroid stimulator (LATS) to thyroid components, and the demonstration of a plasma inhibitor LATS.
    Burke G
    J Lab Clin Med; 1967 May; 69(5):713-27. PubMed ID: 4960804
    [No Abstract]   [Full Text] [Related]  

  • 10. THE PROPERTIES OF FRAGMENTS OF SKIN-SENSITIZING AND BLOCKING ANTIBODIES AS REVEALED BY THE PRAUSNITZ-KUESTNER, PASSIVE CUTANEOUS ANAPHYLAXIS AND HEMAGGLUTINATION REACTIONS.
    GYENES L; SEHON AH; FREEDMAN SO; OVARY Z
    Int Arch Allergy Appl Immunol; 1964; 24():106-18. PubMed ID: 14128914
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the antibody specificity of LATS?
    Fagraeus A; Jonsson J; el-Kabir DJ
    J Clin Endocrinol Metab; 1970 Oct; 31(4):445-7. PubMed ID: 4916544
    [No Abstract]   [Full Text] [Related]  

  • 12. [Discrepancy between thyroid stimulation by LATS and inactivation by thyroid microsomes].
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1970 May; 46(2):122-6. PubMed ID: 5463390
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of the thyroid-stimulating globulin (LATS) by particulate and soluble cell fractions.
    Benhamou-Glynn N; el-Kabir DJ; Doniach D; Roitt IM
    Proc R Soc Med; 1968 Dec; 61(12):1303-5. PubMed ID: 4178461
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced sensitivity of the thyroid to thyrotrophic hormone and LATS following treatment with antimicrosomal antibodies.
    Földes J; Takó J; Bános C; Gesztesi E; Juhász J
    Acta Endocrinol (Copenh); 1973 Dec; 74(4):675-84. PubMed ID: 4800904
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inactivation of the thyroid-stimulating and exophthalmogenic effect of TSH, LATS, EPF, thyroid antibodies and serum protein fractions by iodine].
    Schemmel K; Streich D; Kreysing G; Leybold K; Weisbecker L
    Klin Wochenschr; 1969 Aug; 47(16):879-83. PubMed ID: 5393915
    [No Abstract]   [Full Text] [Related]  

  • 16. On the interaction of long-acting thyroid stimulator with thyroid microsomes.
    Burke G
    J Clin Endocrinol Metab; 1967 Aug; 27(8):1095-102. PubMed ID: 4166580
    [No Abstract]   [Full Text] [Related]  

  • 17. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
    Knight A; Adams DD
    Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
    Pinchera A; Liberti P; De Santis R; Grasso L; Martino E; Baschieri L
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1758-60. PubMed ID: 6072765
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of purified long-acting thyroid stimulator (LATS) and thyroid microsomes in vitro.
    Wong ET; Litman GW
    J Clin Endocrinol Metab; 1969 Jan; 29(1):72-8. PubMed ID: 5762323
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.